Tools | Bookmark & Share | Make MrWhy My Homepage
MrWhy.com
Go
MrWhy.com » Videos » Prof Adam Brufsky - University of Pittsburgh Cancer Institute, USA
Prof Adam Brufsky - University of Pittsburgh Cancer Institute, USA
Prof Adam Brufsky - University of Pittsburgh Cancer Institute,  USA
Report
Prof Adam Brufsky - University of Pittsburgh Cancer Institute, USA
RIBBON-2: A randomized, double-blind, placebo-controlled, phase III trial evaluating the efficacy and safety of bevacizumab in combination with chemotherapy for second-line treatment of HER2-negative metastatic breast cancer. RIBBON-2 results demonstrated that adding bevacizumab to chemotherapy as a second-line treatment for metastatic breast cancer significantly improved progression-free survival.
Channel: www.ecancer.tv
Category: Science
Video Length: 0
Date Found: January 28, 2010
Date Produced:
View Count: 1
 
MrWhy.com Special Offers
1
2
3
4
5
 
About Us: About MrWhy.com | Advertise on MrWhy.com | Contact MrWhy.com | Privacy Policy | MrWhy.com Partners
Answers: Questions and Answers | Browse by Category
Comparison Shopping: Comparison Shopping | Browse by Category | Top Searches
Shop eBay: Shop eBay | Browse by Category
Shop Amazon: Shop Amazon | Browse by Category
Videos: Video Search | Browse by Category
Web Search: Web Search | Browse by Searches
Copyright © 2011 MrWhy.com. All rights reserved.